Article

MI and Perhaps Stroke Risk Increased in Sjögren Syndrome

(EULAR 2014) A large population-based study from Canada finds the risk of myocardial infarction more than tripled in the first year after a Sjögren syndrome diagnosis, and a trend for increased stroke risk.

A retrospective matched-cohort study from Canada has found the risk of myocardial infarction (MI) substantially increased during the first year after diagnosis of Sjögren syndrome, and a trend for increased risk of stroke. The risk for both conditions remains doubled at three-years post-diagnosis, according to these data.

[[{"type":"media","view_mode":"media_crop","fid":"25154","attributes":{"alt":"","class":"media-image","height":"163","id":"media_crop_3098481128543","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"2255","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","title":"Risk of cardiovascular events after Sjögren syndrome diagnosis","typeof":"foaf:Image","width":"344"}}]]

The study by Marko Yurkovich MD of the University of British Columbia and coworkers at the Arthritis Research Centre of Canada headed Antonio Avina-Zubieta MD amassed records separately for the analysis of MI and cerebrovascular accident (CVA) risk, comparing cohorts of 1,176 and 1,195 patients diagnosed with Sjögren syndrome for subsequent MI and CVA events, respectively, against records for nearly 12,000 otherwise similar people who did not have Sjögren syndrome.

This is the first population-based study to address the question of cardiovascular risk in Sjögren syndrome, Yurkovich said at 2014 annual meeting of the European Union League Against Rheumatism (EULAR). The notably increased risk for MI in the first year after diagnosis indicates that the acute inflammatory state is probably the driver for the MI risk, he added.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2025 MJH Life Sciences

All rights reserved.